Nephros (NEPH) Other financing activities (2011 - 2022)

Nephros (NEPH) recorded quarterly Other financing activities of $188000.0 in Q1 2022, up 18700.0% quarter-over-quarter from $1000.0 in Q4 2019.

Nephros (NEPH) Other financing activities (2011 - 2022) Analysis & Trends

Nephros' Other financing activities history runs 4 years deep, the most recent figure standing at $188000.0 for Q1 2022.

In Q1 2022, Other financing activities changed N/A year-over-year to $188000.0; the TTM figure through Dec 2022 stood at $188000.0 (changed N/A YoY), while the FY2022 annual figure was $188000.0, changed N/A from the prior year.
Other financing activities was $188000.0 for Q1 2022 at Nephros, up from $1000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $188000.0 in Q1 2022 to a low of $1000.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn
10	Nephros	34.19 Mn	30.17 Mn	2.99 Mn

Download Data